rasagiline has been researched along with Cacosmia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berkovich, E; Brundin, P; Fitzer-Attas, C; Fog, K; Hickery, M; Kallunki, P; Petit, GH | 1 |
Fauser, M; Haehner, A; Hummel, T; Klingelhöfer, L; Reichmann, H; Storch, A; Wolz, M | 1 |
Habersack, A; Haehner, A; Hummel, T; Reichmann, H; Storch, A; Wienecke, M | 1 |
Alvarez, MV; Grogan, PM | 1 |
2 trial(s) available for rasagiline and Cacosmia
Article | Year |
---|---|
Effects of rasagiline on olfactory function in patients with Parkinson’s disease.
Topics: Administration, Intranasal; Aged; Double-Blind Method; Electroencephalography; Evoked Potentials; Female; Humans; Indans; Male; Middle Aged; Neuroprotective Agents; Olfaction Disorders; Olfactometry; Parkinson Disease; Prospective Studies; Psychophysics; Quality of Life; Severity of Illness Index | 2013 |
Hyposmia in Parkinson's disease.
Topics: Humans; Indans; Monoamine Oxidase Inhibitors; Olfaction Disorders; Parkinson Disease | 2012 |
2 other study(ies) available for rasagiline and Cacosmia
Article | Year |
---|---|
Rasagiline ameliorates olfactory deficits in an alpha-synuclein mouse model of Parkinson's disease.
Topics: Age Factors; alpha-Synuclein; Animals; Disease Models, Animal; Humans; Indans; Memory, Short-Term; Mice; Mice, Transgenic; Monoamine Oxidase Inhibitors; Olfaction Disorders; Olfactory Bulb; Parkinson Disease; Smell | 2013 |
Early Parkinson's disease patients on rasagiline present with better odor discrimination.
Topics: Antiparkinson Agents; Cross-Sectional Studies; Discrimination, Psychological; Female; Humans; Indans; Levodopa; Male; Middle Aged; Neuroprotective Agents; Odorants; Olfaction Disorders; Olfactory Perception; Parkinson Disease; Physical Stimulation; Prospective Studies; Psychophysics; Sensory Thresholds; Severity of Illness Index; Treatment Outcome | 2015 |